Allergan Inc.
(NYSE:AGN)|
36.42 +0.22 (0.61%) Dec 04 - Close |
|
|
|
After-Hours 36.47 +0.05 (0.14%) Thu, 4 Dec 2008 7:40 PM
- Compare AGN with:
- View: Line | Candlestick
Company Profile
Allergan Inc.
2525 Dupont Drive
Irvine, CA 92612
United States - Map
Phone: (714) 246-4500
Fax: (714) 246-4971
Website: www.allergan.com
State of incorporation: Delaware
CEO: David E.I. Pyott
Employees: 7,886
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Mfr/mkt opthalmic & dermatologic products
A health care company, which focused on developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to see more clearly, move more freely and express themselves more fully.
Recent news for AGN
-
Final Glance: Medical Devices companies
AP - 1 hour ago
-
Movers roundup: Arch Chemicals, Williams-Sonoma
AP - 5 hours ago
-
Midday Glance: Medical Devices companies
AP - 6 hours ago
-
Allergan shares rise on eyelash drug outlook
AP - 8 hours ago
-
Early Glance: Medical Devices companies
AP - 9 hours ago
-
Cramer's Mad Money - Will Pfizer Buy Allergan? (12/3/08)
Seeking Alpha - 15 hours ago
-
CNBC - Yesterday at 6:49 ET
-
Final Glance: Medical Devices companies
AP - Yesterday at 5:55 ET
-
Allergan Eye Drug Effective at Enhancing Eyelashes
The Wall Street Journal Online - Yesterday at 3:43 ET
-
UPDATE - Allergan drug lengthens eyelashes -US FDA staff
Reuters - Yesterday at 2:58 ET